SRTS Sensus Healthcare, Inc.

CIK 0001494891 43 ready 8-Ks latest August 13, 2026, 4:13 PM ET RSS · JSON

Activity: NORMAL 1 filings / 30d vs 1 baseline Risk accumulating: auditor change (2)

Ready 8-Ks 43

Latest filing August 13, 2026, 4:13 PM ET

Top materiality 0.85

Event mix earnings ×24 · other_material ×8 · leadership ×6

Sentiment 16 pos · 10 neg · 17 neu

Latest earnings reported 2026-Q1

Executive change recent →

Recent 8-K filings for SRTS

Highest-materiality recent filing

Sensus Healthcare Q1 revenue $10.7M (up 214% YoY); net income $2.3M vs loss of $1.9M

May 9, 2024, 7:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01 ◈ Earnings Releases

Revenue $10.7M, up 214% from $3.4M; shipped 26 systems vs 10 YoY.
Net income $2.3M ($0.14 diluted EPS) vs net loss $1.9M ($0.12 loss) YoY.

Read filing →

August 13, 2026, 4:13 PM ET earnings materiality 0.70 negative item 2.02 item 9.01

Sensus Healthcare Q2 revenue down 68.5% to $2.3M; net loss $8.7M

Revenue $2.3M vs $7.3M in Q2 2025; 11 units sold vs 19, with 8 units deferred to Q3 on financing timing.
June 5, 2026, 4:08 PM ET debt materiality 0.60 neutral item 1.01 item 9.01 ◈ Material Agreements

Sensus Healthcare enters into $15M revolving credit facility with City National Bank of Florida

$15M revolving credit facility; initial $2M available secured by $2.23M cash collateral and blanket asset lien.
May 7, 2026, 7:59 PM ET earnings materiality 0.75 negative item 2.02 item 9.01 ◈ Earnings Releases

Sensus Healthcare Q1 revenue drops to $3.4M; cash $18.3M, no debt

Revenue of $3.4M, down 59% vs $8.3M in Q1 2025; no sales to historically largest customer (15 units in prior year).
February 12, 2026, 6:59 PM ET earnings materiality 0.70 negative item 2.02 item 9.01

Sensus Healthcare Q4 2025 revenue $4.9M, net loss $3.2M; CMS code boost effective Jan 2026

Q4 revenue $4.9M, down from $13.1M YoY; net loss $3.2M ($0.19/sh) vs net income $1.5M ($0.09/sh) in Q4 2024.
November 6, 2025, 6:59 PM ET earnings materiality 0.75 negative item 2.02 item 9.01

Sensus Q3 2025: Revenue down 21.6% to $6.9M; net loss of $0.9M vs profit of $1.2M a year ago

Net loss of $0.9M ($0.06 per share) vs net income of $1.2M ($0.07 diluted) in Q3 2024.
August 7, 2025, 7:59 PM ET earnings materiality 0.75 negative item 2.02 item 9.01

Sensus Healthcare Q2 2025 revenue $7.3M, net loss $1.0M; ships 19 SRT systems, FDA volume up 27% sequentially

Revenue $7.3M vs $9.2M YoY; net loss $1.0M ($0.06/sh) vs net income $1.6M ($0.10/sh) in Q2 2024.
May 15, 2025, 7:59 PM ET earnings materiality 0.70 negative item 2.02 item 9.01

Sensus Healthcare Q1 revenues $8.3M, net loss $2.6M vs. net income $2.3M year ago; forecasts profitability rest of year

Revenue $8.3M, down 22% YoY from $10.7M; net loss $0.16 per share vs. net income $0.14 per diluted share.
February 5, 2025, 6:59 PM ET earnings materiality 0.75 negative item 2.02 item 9.01

Sensus Healthcare Q4 revenue $13.1M, EPS $0.09; record 39 SRT shipments; Q1 sales expected lower

Q4 2024 revenue $13.1M (+4% YoY); full-year revenue $41.8M (+71% YoY).
November 18, 2024, 6:59 PM ET earnings materiality 0.80 positive item 2.02 item 9.01

Sensus Q3 revenues double to $8.8M; net income $1.2M vs loss; targets >50 IG-SRT deals by year-end

Revenue $8.8M (+127% YoY); net income $1.2M ($0.07 diluted EPS) vs net loss $1.5M ($0.09 loss) in Q3 2023.
November 14, 2024, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

Sensus Healthcare Q3 2024 revenue doubles to $8.8M; net income of $0.07 per diluted share

Revenue $8.8M (+127% YoY); net income $1.2M vs net loss $1.5M in Q3 2023.
August 8, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

Sensus Healthcare Q2 2024 revenue $9.2M (+104% YoY); net income $1.6M

Revenue $9.2M vs $4.5M in Q2 2023, up 104%; 23 systems shipped (including 3 to Asia) vs 13 last year.
May 9, 2024, 7:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01 ◈ Earnings Releases

Sensus Healthcare Q1 revenue $10.7M (up 214% YoY); net income $2.3M vs loss of $1.9M

Revenue $10.7M, up 214% from $3.4M; shipped 26 systems vs 10 YoY.
February 8, 2024, 6:59 PM ET earnings materiality 0.70 positive item 2.02 item 9.01 ◈ Earnings Releases

Sensus Healthcare Q4 revenue $12.6M, net income $4.2M; introduces recurring revenue model

Q4 revenue $12.6M (vs $13.1M YoY) but up 3x sequentially from Q3 $3.9M; net income $4.2M ($0.26 diluted EPS) vs $2.8M YoY.
November 9, 2023, 6:59 PM ET earnings materiality 0.75 negative item 2.02 item 9.01 ◈ Earnings Releases

Sensus Healthcare Q3 revenues down 57% YoY to $3.9M; net loss of $1.5M

Revenues $3.9M vs $9.0M Q3 2022; net loss $1.5M ($0.09/sh) vs net income $1.8M ($0.11) prior year.
August 3, 2023, 7:59 PM ET earnings materiality 0.65 negative item 2.02 item 9.01 ◈ Earnings Releases

Sensus Healthcare Q2 revenue $4.5M (-63% YoY), net loss $0.4M vs $3.5M profit last year

Revenue $4.5M, down 63% YoY from $12.1M; net loss $0.4M ($0.02/sh) vs net income $3.5M ($0.21/sh) in Q2 2022.
May 3, 2023, 7:59 PM ET earnings materiality 0.85 negative item 2.02 item 9.01 ◈ Earnings Releases

Sensus Healthcare Q1 2023 revenue $3.4M; net loss $1.9M; expects H2 profitability

Revenue $3.4M vs $10.3M YoY; shipped 10 SRT systems vs 33.
February 9, 2023, 6:59 PM ET earnings materiality 0.60 neutral item 2.02 item 9.01 ◈ Earnings Releases

Sensus Healthcare Q4 net income $2.8M ($0.17 EPS); FY22 revenue up 65% to $44.5M

Q4 2022 revenue $13.1M flat YoY; net income $2.8M ($0.17 diluted EPS) vs $5.3M ($0.32).
January 9, 2023, 6:59 PM ET earnings materiality 0.80 positive item 2.02 item 5.02 item 9.01 ◈ executive_change ×2◈ Earnings Releases

Preliminary FY2022 revenue exceeds $44M (60% growth); profitable Q4 and FY; COO appointed

Preliminary Q4 2022 revenues expected to exceed $13M; full-year 2022 revenues exceed $44M (60% growth over 2021).
November 3, 2022, 7:59 PM ET earnings materiality 0.65 positive item 2.02 item 9.01 ◈ Earnings Releases

Sensus Healthcare Q3 revenue $9.0M (+64% YoY), EPS $0.11 vs $0.01; introduces Silk laser system

Revenue $9.0M (+64% YoY); net income $1.8M ($0.11 diluted EPS) vs $0.2M ($0.01) a year ago.
August 4, 2022, 7:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01

Sensus Healthcare Q2 revenue up 124% to $12.1M; diluted EPS $0.21 vs $(0.02) YoY

Revenue $12.1M, up 124% from $5.4M in Q2 2021; net income $3.5M vs net loss $(0.3M).
May 5, 2022, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

Sensus Healthcare Q1 revenue $10.3M (+237% YoY); net income $0.97/share; launches new product, share buyback

Revenue $10.3M, up 237% YoY; net income $16.1M ($0.97 diluted) vs net loss $1.1M.
March 9, 2022, 6:59 PM ET other material materiality 0.60 positive item 8.01 item 9.01

Sensus Healthcare announces $3M share repurchase program

Board authorized up to $3M in common stock repurchases via open market or block trades.
March 3, 2022, 6:59 PM ET M&A materiality 0.70 neutral item 1.01 item 2.01 item 9.01

Sensus Healthcare sells Sculptura product assets to Empyrean Medical Systems for $15M cash

Purchase price of $15,000,000 in cash plus assumption of certain liabilities relating to Sculptura assets.
February 10, 2022, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

Sensus Healthcare Q4 record revenue $13.0M, EPS $0.32; FY 2021 revenue $27.0M up 182%

Q4 revenue $13.0M (+156% YoY); net income $5.3M ($0.32 diluted EPS) vs $1.0M ($0.06) in Q4 2020.
January 5, 2022, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

Sensus Healthcare expects record Q4 2021 sales over $25M, profitable Q4 and FY

Expects record Q4 sales; full-year 2021 revenue over $25M.
November 4, 2021, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

Sensus Healthcare Q3 revenue $5.5M (+244% YoY); reports first profitable Q3, net income $0.2M

Revenue $5.5M, up 244% from $1.6M in Q3 2020; net income $0.2M vs loss of $1.7M.
August 5, 2021, 7:59 PM ET earnings materiality 0.65 positive item 2.02 item 9.01

Sensus Healthcare Q2 revenue up 358% YoY to $5.4M; net loss narrows to $0.3M

Revenue $5.4M, up 358% YoY and 77% sequentially; shipped 17 systems including 7 SRT-100 Vision.